AU2002234455C1 - Streptococcus pyogenes polypeptides and corresponding DNA fragments - Google Patents

Streptococcus pyogenes polypeptides and corresponding DNA fragments Download PDF

Info

Publication number
AU2002234455C1
AU2002234455C1 AU2002234455A AU2002234455A AU2002234455C1 AU 2002234455 C1 AU2002234455 C1 AU 2002234455C1 AU 2002234455 A AU2002234455 A AU 2002234455A AU 2002234455 A AU2002234455 A AU 2002234455A AU 2002234455 C1 AU2002234455 C1 AU 2002234455C1
Authority
AU
Australia
Prior art keywords
polypeptide
seq
amino acid
acid sequence
isolated polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002234455A
Other languages
English (en)
Other versions
AU2002234455B2 (en
AU2002234455A1 (en
Inventor
Bernard R. Brodeur
Josee Hamel
Denis Martin
Patrick Rheault
Stephane Rioux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Publication of AU2002234455A1 publication Critical patent/AU2002234455A1/en
Assigned to ID BIOMEDICAL CORPORATION reassignment ID BIOMEDICAL CORPORATION Request for Assignment Assignors: SHIRE BIOCHEM INC.
Application granted granted Critical
Publication of AU2002234455B2 publication Critical patent/AU2002234455B2/en
Publication of AU2002234455C1 publication Critical patent/AU2002234455C1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002234455A 2001-02-21 2002-02-21 Streptococcus pyogenes polypeptides and corresponding DNA fragments Ceased AU2002234455C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26984001P 2001-02-21 2001-02-21
US60/269,840 2001-02-21
PCT/CA2002/000207 WO2002066650A2 (en) 2001-02-21 2002-02-21 Streptococcus pyogenes polypeptides and corresponding dna fragments

Publications (3)

Publication Number Publication Date
AU2002234455A1 AU2002234455A1 (en) 2003-02-27
AU2002234455B2 AU2002234455B2 (en) 2008-01-17
AU2002234455C1 true AU2002234455C1 (en) 2008-08-21

Family

ID=23028867

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002234455A Ceased AU2002234455C1 (en) 2001-02-21 2002-02-21 Streptococcus pyogenes polypeptides and corresponding DNA fragments

Country Status (10)

Country Link
US (2) US7482012B2 (enExample)
EP (1) EP1362106B1 (enExample)
JP (1) JP4281861B2 (enExample)
AT (1) ATE456659T1 (enExample)
AU (1) AU2002234455C1 (enExample)
BR (1) BRPI0207447B1 (enExample)
CA (1) CA2438921C (enExample)
DE (1) DE60235223D1 (enExample)
ES (1) ES2338637T3 (enExample)
WO (1) WO2002066650A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343895B1 (en) * 2000-12-21 2008-06-18 ID Biomedical Corporation Streptococcus pyogenes antigens and corresponding dna fragments
AU2008207670B2 (en) * 2001-04-13 2011-06-16 Wyeth Surface proteins of streptococcus pyogenes
EP1390505A2 (en) * 2001-05-02 2004-02-25 Shire Biochem Inc. Antigens of group b streptococcus and corresponding dna fragments
ATE361097T1 (de) * 2002-01-15 2007-05-15 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Orale vakzinierung mit dem tumor-antigen-mimotop gln-met-trp-ala-pro-gln-trp-gly-pro-asp
CN1756843B (zh) * 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原
US7635487B2 (en) 2003-04-15 2009-12-22 Intercell Ag S. pneumoniae antigens
CA2535863A1 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
KR101163425B1 (ko) 2006-04-14 2012-07-13 닛본 덴끼 가부시끼가이샤 개체 식별 방법 및 장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040144A (en) * 1997-07-25 2000-03-21 Mount Sinai School Of Medicine Procedure for preparing gene expression libraries enriched for secretory protein genes
US6033673A (en) * 1998-03-18 2000-03-07 The Administrators Of Tulane Educational Fund Double mutant enterotoxin for use as an adjuvant
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
EP1390505A2 (en) 2001-05-02 2004-02-25 Shire Biochem Inc. Antigens of group b streptococcus and corresponding dna fragments
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
CN1756843B (zh) 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ferretti et al, PNAS, 2001, 98(8):4658-4663 *

Also Published As

Publication number Publication date
CA2438921C (en) 2012-04-10
ATE456659T1 (de) 2010-02-15
AU2002234455B2 (en) 2008-01-17
US20090186820A1 (en) 2009-07-23
WO2002066650A3 (en) 2002-10-31
CA2438921A1 (en) 2002-08-29
JP2004531235A (ja) 2004-10-14
ES2338637T3 (es) 2010-05-11
JP4281861B2 (ja) 2009-06-17
US20030049271A1 (en) 2003-03-13
EP1362106B1 (en) 2010-01-27
DE60235223D1 (de) 2010-03-18
WO2002066650A2 (en) 2002-08-29
US7883706B2 (en) 2011-02-08
EP1362106A2 (en) 2003-11-19
BR0207447A (pt) 2004-06-29
BRPI0207447B1 (pt) 2015-09-22
US7482012B2 (en) 2009-01-27

Similar Documents

Publication Publication Date Title
US7811585B2 (en) Streptococcus pyogenes antigens
US20030232976A1 (en) Streptococcus antigens
KR20010034518A (ko) 그룹 ｂ 스트렙토코커스 항원
US7883706B2 (en) Methods for using Streptococcus pyogenes polypeptides
US20160326221A1 (en) Streptococcus pyogenes antigens and corresponding dna fragments
AU2002234455A1 (en) Streptococcus pyogenes polypeptides and corresponding DNA fragments
EP1660660B1 (en) Pharmaceutical compositions for use in the treatment of Streptococcus Pyogenes infection
AU2001272270B2 (en) Streptococcus pyogenes antigen
WO2002079475A2 (en) Streptococcus pyogenes antigens and corresponding dna fragments
WO2004007725A1 (en) Polypeptide of streptococcus pyogenes
AU2001272270A1 (en) Streptococcus pyogenes antigen

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ID BIOMEDICAL CORPORATION

Free format text: FORMER APPLICANT(S): SHIRE BIOCHEM INC.

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 30 JAN 2008.

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 30 JAN 2008

MK14 Patent ceased section 143(a) (annual fees not paid) or expired